Cetera Trust Company’s AstraZeneca AZN Stock Holding History

Cetera Trust Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$449K	Buy	+2,369	New	+$446K	0.23%	83
2026 Q1	–	Sell	-2,373	Closed	-$436K	–	353
2025 Q4	$436K	Hold	2,373	–	–	0.23%	81
2025 Q3	$364K	Hold	2,373	–	–	0.2%	88
2025 Q2	$332K	Buy	2,373 +100	+4%	+$14K	0.2%	90
2025 Q1	$334K	Hold	2,273	–	–	0.21%	80
2024 Q4	$298K	Buy	2,273 +185	+9%	+$25.9K	0.19%	93
2024 Q3	$325K	Hold	2,088	–	–	0.2%	96
2024 Q2	$326K	Hold	2,088	–	–	0.2%	83
2024 Q1	$283K	Buy	2,088 +238	+13%	+$31.5K	0.17%	108
2023 Q4	$249K	Buy	+1,850	New	+$240K	0.16%	123

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cetera Trust Company's AZN Position: Q2 2026 in Review

Cetera Trust Company opened a new position in AstraZeneca (AZN) in Q2 2026: 2,369 shares worth $449K. The stake represents 0.23% of the portfolio and ranks #83 among its holdings. This is a return to the name: Cetera Trust Company previously reported a position in AZN as recently as Q4 2025.

Cetera Trust Company first reported a position in AZN in Q4 2023 and has held it in 10 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Cetera Trust Company held 2,369 shares of AstraZeneca worth $449K as of Q2 2026.
AstraZeneca was a new Cetera Trust Company position in Q2 2026.
AstraZeneca made up 0.23% of Cetera Trust Company's portfolio in Q2 2026, its #83 holding.
Cetera Trust Company first reported a position in AstraZeneca in Q4 2023 and has held it in 10 quarters since.
1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.